In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that ...

Earlier this month, CRISPR Therapeutics announced positive Phase 1 data for its investigational in vivo CRISPR/Cas9 therapy CTX310, which showed substantial and durable reductions in key lipid levels ...

This biotech has already made impressive contributions to medicine, and it could make more. But does that make it a buy?

Crispr Therapeutics (CRSP) quickly rose 1.3% amid some takeover speculation. Crispr (CRSP) is said to have attracted takeover interest, according to traders, who cited a Betaville "uncooked' alert ...

CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...

Discover how precision biotherapeutics can transform healthcare in India by personalizing treatments based on genetic and ...

CoreWellness founder Bryant Williams, Neighborhood Development Center’s Renay Dossman, Medtronic’s Geoff Martha and Patti and ...